Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics

OBJECTIVE: The objective of this study was to compare persistence, costs, and healthcare resource utilization in patients with schizophrenia and cardiometabolic comorbidities treated with once-monthly paliperidone palmitate or an oral atypical antipsychotic. METHODS: Medicaid data from six states (0...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drugs Real World Outcomes
Egile Nagusiak: Lafeuille, Marie-Hélène, Tandon, Neeta, Tiggelaar, Sean, Kamstra, Rhiannon, Lefebvre, Patrick, Kim, Edward, Yue, Yong, Joshi, Kruti
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2018
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5825393/
https://ncbi.nlm.nih.gov/pubmed/29363022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-018-0130-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak